These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6416723

  • 1. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation.
    McGrath BP, Lim AE, Bode K, Willis GL, Smith GC.
    Clin Exp Pharmacol Physiol; 1983; 10(5):543-53. PubMed ID: 6416723
    [Abstract] [Full Text] [Related]

  • 2. Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
    Lénárd L, Hahn Z.
    Brain Res; 1982 Feb 04; 233(1):115-32. PubMed ID: 6800562
    [Abstract] [Full Text] [Related]

  • 3. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D, Studler JM, Blanc G, Glowinski J, Tassin JP.
    Brain Res; 1986 Sep 24; 383(1-2):47-53. PubMed ID: 3094831
    [Abstract] [Full Text] [Related]

  • 4. Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus.
    López-Sañudo S, Arilla E.
    Regul Pept; 1992 Oct 13; 41(3):227-36. PubMed ID: 1438990
    [Abstract] [Full Text] [Related]

  • 5. Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.
    Kataoka Y, Ohta H, Fujiwara M, Oishi R, Ueki S.
    Neuropharmacology; 1987 Jan 13; 26(1):55-60. PubMed ID: 3031535
    [Abstract] [Full Text] [Related]

  • 6. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS, Smith GP.
    Brain Res; 1980 Oct 20; 199(2):359-84. PubMed ID: 7417789
    [Abstract] [Full Text] [Related]

  • 7. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA.
    J Pharmacol Exp Ther; 1984 Nov 20; 231(2):343-54. PubMed ID: 6149306
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H, McRae-Degueurce A.
    Neurosci Lett; 1982 Jun 30; 30(3):297-301. PubMed ID: 6810240
    [Abstract] [Full Text] [Related]

  • 9. The structure of cerebral cortex in the rat following prenatal administration of 6-hydroxydopamine.
    Lidov HG, Molliver ME.
    Brain Res; 1982 Jan 30; 255(1):81-108. PubMed ID: 6799150
    [Abstract] [Full Text] [Related]

  • 10. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
    Farooqui SM, Zhang K, Makhay M, Jackson K, Farooqui SQ, Cherry JA, O'Donnell JM.
    Brain Res; 2000 Jun 09; 867(1-2):52-61. PubMed ID: 10837797
    [Abstract] [Full Text] [Related]

  • 11. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
    Sarkar DK, Smith GC, Fink G.
    Brain Res; 1981 Jun 01; 213(2):335-49. PubMed ID: 6113874
    [Abstract] [Full Text] [Related]

  • 12. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M, Versteeg DH, de Jong W.
    Hypertension; 1984 Jun 01; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [Abstract] [Full Text] [Related]

  • 13. A study of the neuronal and non-neuronal stores of dopamine in rat and rabbit kidney.
    Soares-da-Silva P.
    Pharmacol Res; 1992 Sep 01; 26(2):161-71. PubMed ID: 1409256
    [Abstract] [Full Text] [Related]

  • 14. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L, MacPhail RC, Heller A, Seiden LS.
    Brain Res; 1979 Mar 23; 164():195-205. PubMed ID: 427556
    [Abstract] [Full Text] [Related]

  • 15. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE, Heffner TG, Kotake C, Seiden LS.
    Brain Res; 1981 Dec 14; 229(1):123-32. PubMed ID: 6796194
    [Abstract] [Full Text] [Related]

  • 16. Intraventricular 6-hydroxydopamine increases the adrenal cortex mitotic activity in rats.
    Lewiński A, Sewerynek E, Konopacki J, Pawlikowski M, Lewińska MK, Smith NK, Reiter RJ.
    Endocr Res; 1984 Dec 14; 10(1):49-61. PubMed ID: 6086299
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravenously administered 6-hydroxydopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat.
    Sheward WJ, Watts AG, Fink G, Smith GC.
    Neurosci Lett; 1985 Apr 09; 55(2):141-4. PubMed ID: 2582316
    [Abstract] [Full Text] [Related]

  • 18. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME, Yuwiler A.
    Psychopharmacology (Berl); 1985 Apr 09; 87(4):484-9. PubMed ID: 3936107
    [Abstract] [Full Text] [Related]

  • 19. Selective catecholamine depletion of structures along the ventral lamina terminalis: effects on experimentally-induced drinking and pressor responses.
    Bellin SI, Landas SK, Johnson AK.
    Brain Res; 1988 Jul 19; 456(1):9-16. PubMed ID: 3136861
    [Abstract] [Full Text] [Related]

  • 20. Distribution of subgroups of neuropeptide Y-immunoreactive and noradrenergic nerves in the female rat uterine cervix.
    Papka RE, Traurig HH.
    Cell Tissue Res; 1988 Jun 19; 252(3):533-41. PubMed ID: 3135119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.